BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23746457)

  • 1. Transplacental transmission of BTV-8 in sheep: BTV viraemia, antibody responses and vaccine efficacy in lambs infected in utero.
    van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Smit M; Vrijenhoek MP; Moulin V; de Smit AJ; Moormann RJ
    Vaccine; 2013 Aug; 31(36):3726-31. PubMed ID: 23746457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.
    van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Vrijenhoek MP; Debyser I; Gregg DA; Dufe DM; Moulin V; Moormann RJ; de Smit AJ
    Vaccine; 2012 Jan; 30(3):647-55. PubMed ID: 22107846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of colostral antibodies with response to a Bluetongue serotype 8 inactivated vaccine in lambs born from hyperimmune ewes.
    Leemans J; Hamers C; Chery R; Bibard A; Besancon L; Duboeuf M; Hudelet P; Goutebroze S; Kirschvink N
    Vaccine; 2013 Apr; 31(15):1975-80. PubMed ID: 23422141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
    Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
    J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine.
    Oura CA; Wood JL; Floyd T; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Simmons H; Batten CA
    Vaccine; 2010 Mar; 28(15):2749-53. PubMed ID: 20123052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine.
    Moulin V; Noordegraaf CV; Makoschey B; van der Sluijs M; Veronesi E; Darpel K; Mertens PP; de Smit H
    Vaccine; 2012 Mar; 30(12):2228-35. PubMed ID: 22207091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of naturally-occurring, trans-placental bluetongue virus serotype-8 infection on reproductive performance in sheep.
    Saegerman C; Bolkaerts B; Baricalla C; Raes M; Wiggers L; de Leeuw I; Vandenbussche F; Zimmer JY; Haubruge E; Cassart D; De Clercq K; Kirschvink N
    Vet J; 2011 Jan; 187(1):72-80. PubMed ID: 20061168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
    Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplacental and oral transmission of wild-type bluetongue virus serotype 8 in cattle after experimental infection.
    Backx A; Heutink R; van Rooij E; van Rijn P
    Vet Microbiol; 2009 Sep; 138(3-4):235-43. PubMed ID: 19419822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of transplacental transmission of bluetongue virus serotype 8 in goats.
    Belbis G; Bréard E; Cordonnier N; Moulin V; Desprat A; Sailleau C; Viarouge C; Doceul V; Zientara S; Millemann Y
    Vet Microbiol; 2013 Oct; 166(3-4):394-404. PubMed ID: 23890676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
    Breard E; Belbis G; Viarouge C; Nomikou K; Haegeman A; De Clercq K; Hudelet P; Hamers C; Moreau F; Lilin T; Durand B; Mertens P; Vitour D; Sailleau C; Zientara S
    Vaccine; 2015 Jan; 33(4):512-8. PubMed ID: 25500308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacental infection and apparently immunotolerance induced by a wild-type bluetongue virus serotype 8 natural infection.
    De Clercq K; De Leeuw I; Verheyden B; Vandemeulebroucke E; Vanbinst T; Herr C; Méroc E; Bertels G; Steurbaut N; Miry C; De Bleecker K; Maquet G; Bughin J; Saulmont M; Lebrun M; Sustronck B; De Deken R; Hooyberghs J; Houdart P; Raemaekers M; Mintiens K; Kerkhofs P; Goris N; Vandenbussche F
    Transbound Emerg Dis; 2008 Oct; 55(8):352-9. PubMed ID: 18673339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bluetongue virus serotype 26: infection kinetics and pathogenesis in Dorset Poll sheep.
    Batten CA; Henstock MR; Bin-Tarif A; Steedman HM; Waddington S; Edwards L; Oura CA
    Vet Microbiol; 2012 May; 157(1-2):119-24. PubMed ID: 22177889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep.
    Oura CA; Wood JL; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Floyd T; Simmons H; Batten CA
    Vaccine; 2009 Dec; 27(52):7326-30. PubMed ID: 19786141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.
    Feenstra F; van Gennip RGP; Maris-Veldhuis M; Verheij E; van Rijn PA
    J Gen Virol; 2014 Sep; 95(Pt 9):2019-2029. PubMed ID: 24914064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplacental infection in goats experimentally infected with a European strain of bluetongue virus serotype 8.
    Coetzee P; Stokstad M; Myrmel M; Mutowembwa P; Loken T; Venter EH; Van Vuuren M
    Vet J; 2013 Aug; 197(2):335-41. PubMed ID: 23422882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.
    Spedicato M; Lorusso A; Salini R; Gennaro AD; Leone A; Teodori L; Casaccia C; Portanti O; Calistri P; Giovannini A; Savini G
    Prev Vet Med; 2017 Jan; 136():49-55. PubMed ID: 28010907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.